Please try another search
PT Taisho Pharmaceutical Indonesia Tbk engages in the development, production, and sale of pharmaceutical products for humans in Indonesia and internationally. The company offers over-the-counter drugs, including topical and children analgesic, multi-vitamin and mineral, and skin care products; and prescription products, such as oral inflammation and stomatitis, corticosteroid, oral and topical antifungal, and antiemetic medicines. PT Taisho Pharmaceutical Indonesia Tbk was formerly known as PT Bristol-Myers Squibb Indonesia Tbk and changed its name to PT Taisho Pharmaceutical Indonesia Tbk on October 28, 2009. The company was founded in 1970 and is based in Jakarta, Indonesia. PT Taisho Pharmaceutical Indonesia Tbk operates as a subsidiary of Taisho Pharmaceutical Holdings Co., Ltd.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review